Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination
Issue Cover
Current Issue
Volume 9,
Issue 2,
January 28 2025

Advertisement intended for health care professionals

17,000 citations
earned in 2023




Featured Content

A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT

Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adults

Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network

Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response

Universal protection of allogeneic T-cell therapies from natural killer cells via CD300a agonism

EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals